title: Acute sarcoidosis as parotid fever in rheumatoid arthritis under anti-tumor necrosis factor-alpha therapy.
authors.forename: Juan
authors.initials: J
authors.lastname: Salvatierra
authors.forename: Cesar
authors.initials: C
authors.lastname: Magro-Checa
authors.forename: Jose L
authors.initials: JL
authors.lastname: Rosales-Alexander
authors.forename: Enrique
authors.initials: E
authors.lastname: Raya-Alvarez
mesh_terms: D000208:Acute Disease; D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D003937:Diagnosis, Differential; D005260:Female; D005334:Fever / Q000139:chemically induced / Q000175:diagnosis; D005500:Follow-Up Studies; D006801:Humans; D008206:Lymphatic Diseases / Q000139:chemically induced / Q000175:diagnosis; D008875:Middle Aged; D010306:Parotid Gland / Q000187:drug effects / Q000503:physiopathology*; D018570:Risk Assessment; D012507:Sarcoidosis / Q000139:chemically induced* / Q000175:diagnosis; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects* / Q000037:antagonists & inhibitors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab